Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Hypertension

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 64 articles:
HTML format



Single Articles


    August 2026
  1. ZHANG H, Wang Q, Liang M, Chen X, et al
    Pulmonary Denervation for Heart Failure-Related Pulmonary Hypertension.
    N Engl J Med. 2026 Aug 30. doi: 10.1056/NEJMoa2609056.
    PubMed     Abstract available


    July 2026
  2. HE J, Mills KT, Chen J
    Hypertension Control in Low-Income Patients. Reply.
    N Engl J Med. 2026;395:103.
    PubMed    


  3. YE L, Lu Q
    Hypertension Control in Low-Income Patients.
    N Engl J Med. 2026;395:102-103.
    PubMed    


  4. ZHENG Z, Jiang X, Wu B
    Hypertension Control in Low-Income Patients.
    N Engl J Med. 2026;395:102.
    PubMed    


  5. YANG Q, Nazarzadeh M, Rahimi K
    Hypertension Control in Low-Income Patients.
    N Engl J Med. 2026;395:101-102.
    PubMed    


    June 2026
  6. OSBORN RR, Hausmann JS, Tan W, Zucker EJ, et al
    Case 16-2026: A 14-Year-Old Girl with Hypertension.
    N Engl J Med. 2026;394:2256-2264.
    PubMed    


    May 2026
  7. BIOLA H, Khan SS, Lloyd-Jones D, Pagidipati NJ, et al
    Cardiovascular Risk Factors - Hypertension.
    N Engl J Med. 2026 May 20. doi: 10.1056/NEJMp2516850.
    PubMed    


    April 2026
  8. ANDERSON CS, Chow CK, de Silva HA, Senanayake B, et al
    Three Low-Dose Antihypertensive Agents in a Single Pill after Intracerebral Hemorrhage.
    N Engl J Med. 2026;394:1571-1582.
    PubMed     Abstract available



  9. Home-Based Care for Hypertension in Rural South Africa.
    N Engl J Med. 2026;394:1560.
    PubMed    


  10. KHAN SS, Huffman MD
    Systems-Based Success for Hypertension.
    N Engl J Med. 2026;394:1445-1446.
    PubMed    


  11. MILLS KT, Krousel-Wood M, Peacock EM, Chen J, et al
    Multifaceted Strategies for Hypertension Control in Low-Income Patients.
    N Engl J Med. 2026;394:1376-1387.
    PubMed     Abstract available


    March 2026
  12. KOTANIDIS CP, Whelton PK, Wright CB
    Blood-Pressure Targets in Hypertension Management.
    N Engl J Med. 2026;394:1026-1029.
    PubMed    


    February 2026
  13. BENETOS A, Gautier S, Rossignol P
    Reduction of Antihypertensive Treatment in Nursing Home Residents. Reply.
    N Engl J Med. 2026;394:932-933.
    PubMed    


  14. FUJI S
    Reduction of Antihypertensive Treatment in Nursing Home Residents.
    N Engl J Med. 2026;394:932.
    PubMed    


  15. ZHANG L, Yang L
    Reduction of Antihypertensive Treatment in Nursing Home Residents.
    N Engl J Med. 2026;394:931-932.
    PubMed    


  16. HUART J, Jouret F
    Reduction of Antihypertensive Treatment in Nursing Home Residents.
    N Engl J Med. 2026;394:931.
    PubMed    


  17. LU Y, Li L
    Reduction of Antihypertensive Treatment in Nursing Home Residents.
    N Engl J Med. 2026;394:930-931.
    PubMed    


  18. STRANDBERG TE
    Reduction of Antihypertensive Treatment in Nursing Home Residents.
    N Engl J Med. 2026;394:930.
    PubMed    


  19. FADAKAR PK, Pourvaziri A, Feldman AS, Pier DB, et al
    Case 5-2026: An 18-Year-Old Woman with Headache and Hypertension.
    N Engl J Med. 2026;394:700-709.
    PubMed    


    January 2026
  20. KISHORE SP, Kocher R
    The Hypertension Control Paradox - Why Is America Stuck?
    N Engl J Med. 2026;394:417-420.
    PubMed    


  21. HORTON JC
    Idiopathic Intracranial Hypertension. Reply.
    N Engl J Med. 2026;394:414-415.
    PubMed    


  22. WANG Y, Liang Z, Weng D
    Idiopathic Intracranial Hypertension.
    N Engl J Med. 2026;394:414.
    PubMed    


  23. XIAO YJ, Sun H
    Idiopathic Intracranial Hypertension.
    N Engl J Med. 2026;394:414.
    PubMed    


  24. DO LAGO V, Caldas J
    Idiopathic Intracranial Hypertension.
    N Engl J Med. 2026;394:414.
    PubMed    


  25. FLACK JM, Dwyer JP, Williams B
    Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension. Reply.
    N Engl J Med. 2026;394:305-306.
    PubMed    


  26. JHAVERI KD, Hirsch JS, Fishbane S
    Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension.
    N Engl J Med. 2026;394:305.
    PubMed    


  27. ZHENG Z, Jiang X, Wu B
    Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension.
    N Engl J Med. 2026;394:304.
    PubMed    


  28. HIGASHI Y
    Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension.
    N Engl J Med. 2026;394:304.
    PubMed    


  29. PEDREIRA-BOUZAS J, Pousada-Fonseca A
    Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension.
    N Engl J Med. 2026;394:303-304.
    PubMed    


    November 2025
  30. GOREY S, Rothberg M, Chang TI
    To Treat or Not to Treat? Watchful Waiting or Oral Antihypertensives for Asymptomatic Inpatient Hypertension.
    N Engl J Med. 2025;393:2051-2053.
    PubMed    


  31. PLACIDO R, Baptista B
    Ortner's Syndrome in Pulmonary Hypertension.
    N Engl J Med. 2025;393:e35.
    PubMed    


  32. JIMENEZ C, Andreassen M, Durand A, Moog S, et al
    Belzutifan for Advanced Pheochromocytoma or Paraganglioma.
    N Engl J Med. 2025;393:2012-2022.
    PubMed     Abstract available


    October 2025
  33. HORTON JC
    Idiopathic Intracranial Hypertension.
    N Engl J Med. 2025;393:1409-1419.
    PubMed    


    September 2025
  34. MCLAUGHLIN VV, Hoeper MM, Badesch DB, Ghofrani HA, et al
    Sotatercept for Pulmonary Arterial Hypertension within the First Year after Diagnosis.
    N Engl J Med. 2025 Sep 30. doi: 10.1056/NEJMoa2508170.
    PubMed     Abstract available


  35. SIEDNER MJ, Magula N, Mazibuko L, Sithole N, et al
    Home-Based Care for Hypertension in Rural South Africa.
    N Engl J Med. 2025 Sep 1. doi: 10.1056/NEJMoa2509958.
    PubMed     Abstract available


    August 2025
  36. FLACK JM, Azizi M, Brown JM, Dwyer JP, et al
    Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension.
    N Engl J Med. 2025 Aug 30. doi: 10.1056/NEJMoa2507109.
    PubMed     Abstract available


  37. GUZIK TJ, Tomaszewski M
    Aldosterone Synthase Inhibition for Hypertension.
    N Engl J Med. 2025 Aug 30. doi: 10.1056/NEJMe2511533.
    PubMed    


  38. BENETOS A, Gautier S, Freminet A, Metz A, et al
    Reduction of Antihypertensive Treatment in Nursing Home Residents.
    N Engl J Med. 2025 Aug 29. doi: 10.1056/NEJMoa2508157.
    PubMed     Abstract available


  39. LAFFIN LJ, Rodman D, Nissen SE
    Lorundrostat Efficacy and Safety in Uncontrolled Hypertension. Reply.
    N Engl J Med. 2025;393:726-727.
    PubMed    


  40. POLLOCK JM 3RD
    Lorundrostat Efficacy and Safety in Uncontrolled Hypertension.
    N Engl J Med. 2025;393:726.
    PubMed    


  41. BURGOS E, Fernandez Fernandez B, Ortiz A
    Lorundrostat Efficacy and Safety in Uncontrolled Hypertension.
    N Engl J Med. 2025;393:725-726.
    PubMed    


    June 2025
  42. GARVEY WT, Bluher M, Osorto Contreras CK, Davies MJ, et al
    Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity.
    N Engl J Med. 2025 Jun 22. doi: 10.1056/NEJMoa2502081.
    PubMed     Abstract available


    May 2025
  43. MARON BA
    Sotatercept and the Clinical Transformation of Pulmonary Arterial Hypertension.
    N Engl J Med. 2025;392:2059-2061.
    PubMed    


    April 2025
  44. LAFFIN LJ, Kopjar B, Melgaard C, Wolski K, et al
    Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension.
    N Engl J Med. 2025 Apr 23. doi: 10.1056/NEJMoa2501440.
    PubMed     Abstract available


    March 2025
  45. HUMBERT M, McLaughlin VV, Badesch DB, Ghofrani HA, et al
    Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for Death.
    N Engl J Med. 2025 Mar 31. doi: 10.1056/NEJMoa2415160.
    PubMed     Abstract available


  46. MAGNUSSEN C, Alegre-Diaz J, Al-Nasser LA, Amouyel P, et al
    Global Effect of Cardiovascular Risk Factors on Lifetime Estimates.
    N Engl J Med. 2025 Mar 30. doi: 10.1056/NEJMoa2415879.
    PubMed     Abstract available


    January 2025
  47. VAIDYA A, Morlote M, Moussa M, Barletta J, et al
    Targeting a Hormonal Cause of Hypertension.
    N Engl J Med. 2025;392:e14.
    PubMed    


    November 2024
  48. BI Y, Li M, Liu Y, Li T, et al
    Intensive Blood-Pressure Control in Patients with Type 2 Diabetes.
    N Engl J Med. 2024 Nov 16. doi: 10.1056/NEJMoa2412006.
    PubMed     Abstract available


    June 2024
  49. MANRIQUE-ACEVEDO C, Hirsch IB, Eckel RH
    Prevention of Cardiovascular Disease in Type 1 Diabetes. Reply.
    N Engl J Med. 2024;390:2227.
    PubMed    


    May 2024
  50. NAJEM M, Dong E
    Esophageal Varices, White-Nipple Sign, and Portal Hypertensive Gastropathy.
    N Engl J Med. 2024;390:e47.
    PubMed    


  51. LI G, Lin Y, Yang J, Anderson CS, et al
    Intensive Ambulance-Delivered Blood-Pressure Reduction in Hyperacute Stroke.
    N Engl J Med. 2024 May 16. doi: 10.1056/NEJMoa2314741.
    PubMed     Abstract available


  52. EDLOW JA
    Lowering Blood Pressure in Stroke Patients in the Ambulance - A Bridge Too Close?
    N Engl J Med. 2024 May 16. doi: 10.1056/NEJMe2402356.
    PubMed    


    April 2024
  53. KUROLAP A, Chai Gadot C, Baris Feldman H
    Corin and Left Atrial Cardiomyopathy, Hypertension, Arrhythmia, and Fibrosis. Reply.
    N Engl J Med. 2024;390:1539-1540.
    PubMed    


  54. ABASSI Z, Azzam ZS, Heyman SN
    Corin and Left Atrial Cardiomyopathy, Hypertension, Arrhythmia, and Fibrosis.
    N Engl J Med. 2024;390:1539.
    PubMed    


  55. GLADYSHEVA IP, Wang D, Reed GL
    Corin and Left Atrial Cardiomyopathy, Hypertension, Arrhythmia, and Fibrosis.
    N Engl J Med. 2024;390:1538-1539.
    PubMed    


  56. DOMINY J, Koch C, Lamarche L, Denning D, et al
    Corin and Left Atrial Cardiomyopathy, Hypertension, Arrhythmia, and Fibrosis.
    N Engl J Med. 2024;390:1537-1538.
    PubMed    


  57. CHEN B, Wei M
    Aortic Coarctation.
    N Engl J Med. 2024;390:1420.
    PubMed    


  58. VAZQUEZ MA, Oliver G, Amarasingham R, Sundaram V, et al
    Pragmatic Trial of Hospitalization Rate in Chronic Kidney Disease.
    N Engl J Med. 2024;390:1196-1206.
    PubMed     Abstract available


    December 2023
  59. JAUREGUI R, Busis NA
    Idiopathic Intracranial Hypertension.
    N Engl J Med. 2023;389:2467.
    PubMed    


    November 2023
  60. BARIS FELDMAN H, Chai Gadot C, Zahler D, Mory A, et al
    Corin and Left Atrial Cardiomyopathy, Hypertension, Arrhythmia, and Fibrosis.
    N Engl J Med. 2023;389:1685-1692.
    PubMed     Abstract available


    October 2023
  61. DESAI AS, Sweetser MT, Bakris GL
    Zilebesiran for Hypertension. Reply.
    N Engl J Med. 2023;389:1439-1440.
    PubMed    


  62. VAN TWIST DJL, Kalic H
    Zilebesiran for Hypertension.
    N Engl J Med. 2023;389:1438-1439.
    PubMed    


  63. LIFSCHITZ M
    Zilebesiran for Hypertension.
    N Engl J Med. 2023;389:1438.
    PubMed    


  64. ABASHEVA D, Fernandez-Fernandez B, Ortiz A
    Zilebesiran for Hypertension.
    N Engl J Med. 2023;389:1438.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Hypertension is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum